These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2492742)

  • 1. Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study.
    Wall TC; Mark DB; Califf RM; Collins G; Burgess R; Skelton TN; Hinohara T; Kong DF; Mantell S; Aronson L
    Am J Cardiol; 1989 Feb; 63(7):423-8. PubMed ID: 2492742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Reiner JS; Lundergan CF; van den Brand M; Boland J; Thompson MA; Machecourt J; Py A; Pilcher GS; Fink CA; Burton JR
    J Am Coll Cardiol; 1994 Nov; 24(6):1439-44. PubMed ID: 7930273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome.
    Grines CL; Topol EJ; Bates ER; Juni JE; Walton JA; O'Neill WW
    Am Heart J; 1988 Jan; 115(1 Pt 1):1-7. PubMed ID: 2962478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Gibson CM; Cannon CP; Piana RN; Breall JA; Sharaf B; Flatley M; Alexander B; Diver DJ; McCabe CH; Flaker GC
    J Am Coll Cardiol; 1995 Mar; 25(3):582-9. PubMed ID: 7860900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial). Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis.
    Veen G; de Boer MJ; Zijlstra F; Verheugt FW
    Am J Cardiol; 1999 Oct; 84(7):763-7. PubMed ID: 10513770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty.
    Juliard JM; Himbert D; Cristofini P; Desportes JC; Magne M; Golmard JL; Aubry P; Benamer H; Boccara A; Karrillon GJ; Steg PG
    Am J Cardiol; 1999 Feb; 83(3):305-10. PubMed ID: 10072213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-hour balloon inflation to resolve recurrent reocclusion during coronary angioplasty.
    Brenner AS; Browne KF
    Cathet Cardiovasc Diagn; 1991 Feb; 22(2):107-11. PubMed ID: 1901243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of patients with < 60% to > or = 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. The TIMI Investigators.
    Schweiger MJ; McMahon RP; Terrin ML; Ruocco NA; Porway MN; Wiseman AH; Knatterud GL; Braunwald E
    Am J Cardiol; 1994 Jul; 74(2):105-10. PubMed ID: 8023772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction.
    de Boer MJ; Reiber JH; Suryapranata H; van den Brand MJ; Hoorntje JC; Zijlstra F
    Eur Heart J; 1995 Oct; 16(10):1347-55. PubMed ID: 8746902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study Group.
    Haq A; Morgan CD; Wilson RF; Daly PA; Baigrie RS; White CW; Roberts R; Gent M; Armstrong PW
    Am J Cardiol; 1993 Aug; 72(5):379-83. PubMed ID: 8352178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction.
    Kievit PC; Brouwer MA; Veen G; Karreman AJ; Verheugt FW
    Am Heart J; 2004 Nov; 148(5):826-33. PubMed ID: 15523313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity.
    French JK; Ellis CJ; Webber BJ; Williams BF; Amos DJ; Ramanathan K; Whitlock RM; White HD
    Am J Cardiol; 1998 Mar; 81(6):665-71. PubMed ID: 9527071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis.
    Veen G; Meyer A; Verheugt FW; Werter CJ; de Swart H; Lie KI; van der Pol JM; Michels HR; van Eenige MJ
    J Am Coll Cardiol; 1993 Dec; 22(7):1755-62. PubMed ID: 8245325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction.
    Kalbfleisch J; Thadani U; LittleJohn JK; Brown G; Magorien R; Kutcher M; Taylor G; Maddox WT; Campbell WB; Perry J
    Am J Cardiol; 1992 May; 69(14):1120-7. PubMed ID: 1575179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial.
    Gibson CM; Cannon CP; Greene RM; Sequeira RF; Margorien RD; Leya F; Diver DJ; Baim DS; Braunwald E
    Am J Cardiol; 1997 Jul; 80(1):21-6. PubMed ID: 9205014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early reocclusion after successful thrombolysis is related to lesion length and roughness.
    de Cesare NB; Ellis SG; Williamson PR; Deboe SF; Pitt B; Mancini GB
    Coron Artery Dis; 1993 Feb; 4(2):159-66. PubMed ID: 8269207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST segment tracking for rapid determination of patency of the infarct-related artery in acute myocardial infarction.
    Fernandez AR; Sequeira RF; Chakko S; Correa LF; de Marchena EJ; Chahine RA; Franceour DA; Myerburg RJ
    J Am Coll Cardiol; 1995 Sep; 26(3):675-83. PubMed ID: 7642858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.